Eisai
4523.T
#2294
Rank
HK$64.85 B
Marketcap
HK$229.90
Share price
3.92%
Change (1 day)
4.81%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): HK$6.78

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$6.77. an increase over its 2024 EPS that were of HK$7.63.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025HK$8.5311.85%
2024HK$7.63-32.63%
2023HK$11.335.52%
2022HK$10.73-74.01%
2021HK$41.29-66.58%
2020HK$123.5498.24%
2019HK$62.3117.01%
2018HK$53.2637.78%
2017HK$38.65-27.62%
2016HK$53.4035.33%
2015HK$39.46-2.82%
2014HK$40.61-27.66%
2013HK$56.14-27.49%
2012HK$77.43-12.67%
2011HK$88.6688.08%
2010HK$47.14-11.06%
2009HK$53.01-390.15%
2008-HK$18.27-127.78%
2007HK$65.7711.78%
2006HK$58.844.38%
2005HK$56.377.4%
2004HK$52.4943.03%
2003HK$36.7025.09%
2002HK$29.3452.67%
2001HK$19.2269.76%
2000HK$11.32